These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 35955526)

  • 1. Specific Isolation of
    Zhang Z; Douillard FP; Korkeala H; Lindström M
    Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35955526
    [No Abstract]   [Full Text] [Related]  

  • 2. Phage lysin that specifically eliminates Clostridium botulinum Group I cells.
    Zhang Z; Lahti M; Douillard FP; Korkeala H; Lindström M
    Sci Rep; 2020 Dec; 10(1):21571. PubMed ID: 33299101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diversity of the Genomes and Neurotoxins of Strains of
    Brunt J; van Vliet AHM; Carter AT; Stringer SC; Amar C; Grant KA; Godbole G; Peck MW
    Toxins (Basel); 2020 Sep; 12(9):. PubMed ID: 32932818
    [No Abstract]   [Full Text] [Related]  

  • 4. Development of An Innovative and Quick Method for the Isolation of
    Le Gratiet T; Poezevara T; Rouxel S; Houard E; Mazuet C; Chemaly M; Maréchal CL
    Toxins (Basel); 2020 Jan; 12(1):. PubMed ID: 31936866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differentiating Botulinum Neurotoxin-Producing Clostridia with a Simple, Multiplex PCR Assay.
    Williamson CHD; Vazquez AJ; Hill K; Smith TJ; Nottingham R; Stone NE; Sobek CJ; Cocking JH; Fernández RA; Caballero PA; Leiser OP; Keim P; Sahl JW
    Appl Environ Microbiol; 2017 Sep; 83(18):. PubMed ID: 28733282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel Lytic Enzyme of Prophage Origin from
    Morzywolek A; Plotka M; Kaczorowska AK; Szadkowska M; Kozlowski LP; Wyrzykowski D; Makowska J; Waters JJ; Swift SM; Donovan DM; Kaczorowski T
    Int J Mol Sci; 2021 Sep; 22(17):. PubMed ID: 34502443
    [No Abstract]   [Full Text] [Related]  

  • 7. Multi-dimensional nanoscale liquid chromatography and nano-electrospray ion-trap mass spectrometry for detection of Clostridium botulinum type C and the produced botulinum neurotoxin type C complex.
    Plößl T; Vujtovic-Ockenga N; Kehrenberg C; Klaubert B
    J Microbiol Methods; 2022 Feb; 193():106397. PubMed ID: 34952090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clostridium botulinum in the post-genomic era.
    Peck MW; Stringer SC; Carter AT
    Food Microbiol; 2011 Apr; 28(2):183-91. PubMed ID: 21315972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of Clostridium botulinum group III's mobilome content.
    Woudstra C; Le Maréchal C; Souillard R; Anniballi F; Auricchio B; Bano L; Bayon-Auboyer MH; Koene M; Mermoud I; Brito RB; Lobato FCF; Silva ROS; Dorner MB; Fach P
    Anaerobe; 2018 Feb; 49():71-77. PubMed ID: 29287670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pan-Genomic Analysis of
    Brunt J; van Vliet AHM; Stringer SC; Carter AT; Lindström M; Peck MW
    Toxins (Basel); 2020 May; 12(5):. PubMed ID: 32397147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenotypic characterization of Clostridium botulinum strains isolated from infant botulism cases in Argentina.
    Sagua MD; Lúquez C; Barzola CP; Bianco MI; Fernández RA
    Rev Argent Microbiol; 2009; 41(3):141-7. PubMed ID: 19831311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulatory Networks Controlling Neurotoxin Synthesis in
    Popoff MR; Brüggemann H
    Toxins (Basel); 2022 May; 14(6):. PubMed ID: 35737025
    [No Abstract]   [Full Text] [Related]  

  • 13. Identification of Cross Reactive Antigens of C. botulinum Types A, B, E & F by Immunoproteomic Approach.
    Sharma A; Ponmariappan S; Sarita R; Alam SI; Kamboj DV; Shukla S
    Curr Microbiol; 2018 May; 75(5):531-540. PubMed ID: 29332140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genomes, neurotoxins and biology of Clostridium botulinum Group I and Group II.
    Carter AT; Peck MW
    Res Microbiol; 2015 May; 166(4):303-17. PubMed ID: 25445012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of antibiotics on the viability of and toxin production by Clostridium botulinum.
    Yutani M; Matsumura T; Fujinaga Y
    Microbiol Immunol; 2021 Oct; 65(10):432-437. PubMed ID: 34219270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First report of an infant botulism case due to Clostridium botulinum type Af.
    de Jong LI; Fernández RA; Pareja V; Giaroli G; Guidarelli SR; Dykes JK; Lúquez C
    J Clin Microbiol; 2015 Feb; 53(2):740-2. PubMed ID: 25502535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biology and genomic analysis of Clostridium botulinum.
    Peck MW
    Adv Microb Physiol; 2009; 55():183-265, 320. PubMed ID: 19573697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved detection methods by genetic and immunological techniques for botulinum C/D and D/C mosaic neurotoxins.
    Nakamura K; Kohda T; Seto Y; Mukamoto M; Kozaki S
    Vet Microbiol; 2013 Mar; 162(2-4):881-890. PubMed ID: 23206412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Independent evolution of neurotoxin and flagellar genetic loci in proteolytic Clostridium botulinum.
    Carter AT; Paul CJ; Mason DR; Twine SM; Alston MJ; Logan SM; Austin JW; Peck MW
    BMC Genomics; 2009 Mar; 10():115. PubMed ID: 19298644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the D/C mosaic neurotoxin produced by Clostridium botulinum associated with bovine botulism in Japan.
    Nakamura K; Kohda T; Umeda K; Yamamoto H; Mukamoto M; Kozaki S
    Vet Microbiol; 2010 Jan; 140(1-2):147-54. PubMed ID: 19720474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.